Recombinant PCSK9 (Frovocimab Biosimilar) antibody

Catalog No. ABIN7829357

The Humanized Monoclonal anti-PCSK9 (Frovocimab Biosimilar) antibody is suitable to detect PCSK9 (Frovocimab Biosimilar) in samples from Human.

Quick Overview for Recombinant PCSK9 (Frovocimab Biosimilar) antibody (ABIN7829357)

Target: PCSK9 (Frovocimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This PCSK9 (Frovocimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-PCSK9 (Frovocimab Biosimilar) Antibody

Purpose: Anti-PCSK9(frovocimab biosimilar) mAb

Isotype: IgG4

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for PCSK9 (Frovocimab Biosimilar)

Target: PCSK9 (Frovocimab Biosimilar)

Alternative Name: Frovocimab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:FH3,PC9,FHCL3,NARC1,LDLCQ1,NARC-1,HCHOLA3
Synonyms Antibody:LY3015014,LY-3015014,LY 3015014

UniProt: Q8NBP7